Effective Interventions for Optimal Patient Care in Parkinson’s Disease: Guidance for Nurse Practitioners and Physician Assistants

Slide Lecture with Audio

Sponsored by North American Center for Continuing Medical Education, LLC

Presenter/Q&A Cohost

Thomas L. Davis, MD
Associate Professor of Neurology
Director, Division of Movement Disorders
Vanderbilt University, School of Medicine
Medical Center North
Nashville, Tennessee

Q&A Cohosts

Gwyn M. Vernon, MSN, CRNP
Certified Family and Neurological Nurse Practitioner
Pennsylvania Comprehensive Neuroscience Center
University of PA School of Nursing
Philadelphia, Pennsylvania

Colleen D. Knoop, MSN, ARNP, FNP, NP-C
Division of Movement Disorders
University of Louisville
Louisville, Kentucky

Target Audience

This activity is designed for nurse practitioners and physician assistants.

Learning Objectives

After completing this activity, participants should be able to:

Implement methods, such as tracking patient history, to identify preclinical nonmotor features of Parkinson’s Disease (PD) and facilitate early treatment
Identify the benefits and limitations of PD medications relevant to their use in different stages of the disease and in conjunction with medications for common comorbidities
Summarize current data regarding the impact of disease-modifying drugs on neuroprotection in PD management
Assist in monitoring patients with PD to promote medication adherence and optimize outcomes

Activity Overview

The on-demand slide lecture with audio is available with html slides and the presentation transcript. To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online at www.naccme.com, may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: May 13, 2010

Expiration Date: May 13, 2011

Estimated time to complete: 1 hour

For questions regarding this educational activity, please call 609-371-1137

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AANP Accreditation

This program is approved for 1.0 contact hours of continuing education by the American Academy of Nurse Practitioners. Program ID 1002033.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

Independent Clinical Reviewer: Daniel Claassen, MD, Instructor of Neurology, Department of Neurology, University of Virginia, Charlottesville, Virginia

Planning Committee

The planning committee comprises Thomas Davis, MD; Daniel Claassen, MD; Colleen Knoop, NP-C; Gwyn Vernon, CRNP; Mike Kearney, Donna Kruggel, Emilie McCardell, Nick Lombardi, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Davis: Consultant—Schwarz Pharma LLC; Grant/Research support— Allergan, Medtronic Inc.; Promotional speakers bureau—Allergan, Boehringer Ingelheim, GlaxoSmithKline,Teva Pharmaceuticals, Novartis
Dr. Claassen: Clinical Research Fellowship—American Academy of Neurology
Ms. Knoop: Has disclosed no relevant financial relationships with any commercial interests
Ms. Vernon: Consultant—Ipsen Pharmaceuticals, Medtronic Inc., Teva Pharmaceuticals; Promotional speakers bureau— Ipsen Pharmaceuticals, Medtronic Inc., Teva Pharmaceuticals

Mr. Kearney, Ms. Kruggel, Ms. McCardell, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

Mr. Lombardi: Stock Shareholder—Inspire Pharmaceuticals, Viro Pharmaceuticals, Vertex Pharmaceuticals, Inc.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: The use of amantadine for the treatment of Parkinson’s Disease.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education, LLC.

Grant Support

Supported by an educational grant from Teva Neuroscience